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Endotracheal intubation is a common neonatal 
procedure and essential for the provision of neonatal 
intensive care. The procedure induces noxious stimuli 
often associated with adverse physiological events 
such as raised intracranial pressure,[1] hypoxaemia 
and cardiovascular instability.[2] Premedication regimens may include 
a vagolytic to reduce vagal-induced bradycardia, a narcotic/sedative 
agent that attenuates increases in systemic blood pressure, and a 
muscle relaxant that attenuates increases in intracranial pressure.[3]
Recent studies have shown that premedication for elective and 
semi-urgent intubation of infants significantly improves intubation 
conditions, decreases the time and number of attempts needed to 
complete the intubation procedure, and minimises the potential for 
intubation-related airway trauma.[4-6] However, despite the growing 
body of evidence and acceptance of premedication as a standard 
of care, its use is still not universal, and wide variations occur in 
practice.[7,8]
Premedication practices have been surveyed in Europe,[7,9,10] North 
America[8,11] and Australia.[12] The European surveys had a profound 
effect on current practice. Whyte et al.[7] demonstrated in a study 
conducted in 1998 that 63% of UK neonatal units did not use 
premedication prior to intubation, their study prompting much 
discussion. A decade later, when the survey was repeated, ≥90% of 
neonatal units had adopted premedication as standard of care.[9,10]
Because current neonatal premedication practices have not 
previously been surveyed in South Africa (SA), we designed a survey 
with the objective of determining the current practice and standard 
of care. This survey may provide data that could inform the design 
of collaborative trials and/or stimulate debate that ultimately leads to 
change and standardisation of practice.
Methods
The study was designed as a cross-sectional survey of clinicians 
working in SA state and private neonatal intensive care units. This 
research was approved by the Human Research Ethics Committee, 
Faculty of Health Sciences, University of Cape Town.
Potential participants were identified from an online listing 
of 147 neonatal intensive care units in hospitals across SA 
on the Medpages directory website.[13] The names and contact 
details of the clinicians working in those units were obtained 
by searching the websites of the respective hospitals. Additional 
names and contact details of clinicians involved in neonatal care 
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were obtained from a local departmental 
database. Clinicians who did not treat 
neonates in their practice were excluded. 
Clinicians did not receive incentives to 
participate in the survey.
The survey questionnaire was created 
and hosted using Survey Monkey, an 
online survey website. The questionnaire 
enabled compilation of data regarding use 
of premedication and whether a written 
policy existed for sedating preterm infants 
before elective or semi-elective intubation. 
The questionnaire was designed to 
determine which agent/s were most used 
for premedication, as well as the doses 
used. The questionnaire was brief, taking 
no more than 3 minutes to complete. 
Each question addressed a single point 
and in most cases required a ‘yes’ or 
‘no’ response. An e-mail containing an 
individualised link to the survey was sent 
to 481 clinicians on 1 October 2013. The 
Survey Monkey collector tool collected all 
responses anonymously and automatically 
sent reminder e-mails to those who had 
not responded. Survey collection closed on 
14 November 2013.
Data analysis
Responses were exported to a Microsoft 
Excel file. Data were analysed with Stata 
version 12 (Stata Corporation, USA). Chi-
square and Fisher’s exact tests were used 
for comparison of categorical variables. 
Descriptive results were expressed as 
numbers and proportions (%). A p-value of 
<0.05 was considered significant.
Results
We received responses to 136 of the 481 
emails sent (28.3%). The characteristics 
of the respondents surveyed are shown 
in Table 1. Sixty-six responses (54.1%) 
were from clinicians in the private sector 
and 56 (45.9%) from those in the state 
sector. The majority of respondents were 
paediatricians or neonatologists. The 
majority of paediatricians (76.0%) worked 
in the private sector, whereas 78.6% of 
neonatologists worked in the state sector, 
typically in medium-sized neonatal units 
with six to ten beds.
A subgroup analysis comparing pre-
medication practices between the public and 
private sectors is reported in Table 2. A 
written policy was used by a minority of 
clinicians, more often in the public sector 
(p<0.0001).
Premedication prior to intubation 
was practised by 71.9% of respondents; 
however, only 38.5% of neonatal units had 
a written policy. The respondents routinely 
used sedatives for premedication, but not 
muscle relaxants or atropine. These data are 
reported in Table 3 and Fig. 1. Midazolam, 
morphine and ketamine were the most 
commonly used sedative agents (Fig. 2). 
When muscle relaxants were administered, 
suxamethonium (95.2%) was the muscle 
relaxant of choice.
Table 4 illustrates varied combinations 
of agents or single agents used for 
premedication. Seven premedication drugs 
were used in 16 different combinations/
regimens, utilising one to three drugs. 
Midazolam was the drug most commonly 
used as a single agent.
Table 5 illustrates the drug dose 
ranges. Most respondents stated specific 
doses for the choice of drug used: 33.3% 
speci fied a morphine dose of 0.1 mg/
kg, whereas 39.0% said that they would 
administer a dose of 0.2 mg/kg. Midazolam 
dosing varied, respondents using doses 
of 0.1  mg/kg (36.4%), 0.15 mg/kg (13.6%), 
0.2 mg/kg (22.7%) and 0.4 mg/kg (4.5%). 
For suxa methonium, 55.0% of respondents 
used a dose of 2 mg/kg. 
Table 1. Characteristics of neonatal 
units surveyed (N=136)
n (%)
Nature of practice
Private health sector 66 (54.1)
Public health sector 56 (45.9)
Rank 
Medical officer 9 (6.6)
Registrar 6 (4.4)
Paediatrician 78 (57.4)
Neonatologist 28 (20.6)
Other specialist 5 (3.7)
Not a medical doctor 10 (7.4)
ICU beds
0 3 (2.5)
1 - 5 35 (28.7)
6 - 10 50 (41.0)
>10 34 (27.9)
Table 2. Subgroup analysis
Premedication practice Private sector, n (%) Public sector, n (%) p-value
Written policy present 15 (31.9) 32 (68.0) <0.0001
Routine use of any 
premedication agent
46 (52.9) 41 (47.1) 0.8
Routine use of sedatives 25 (45.5) 30 (54.6) 0.13
Routine use of muscle relaxants 10 (47.6) 11 (52.4) 0.62
Routine use of atropine 15 (45.5) 18 (54.6) 0.315
Only when bradycardic
Never
Routine
Percentage
0 10 20 30 40 50 60
38.8%
49.4%
11.8%
Fig. 1. Atropine use for premedication.
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Discussion
A greater understanding of neonatal pain 
and the knowledge that noxious stimuli 
such as intubation may have long-term 
deleterious effects[13] have prompted 
consensus statements[14-16] advocating the use 
of premedication as standard of care.
This study illustrates that almost 30% 
of the SA clinicians surveyed were not 
administering premedication to infants 
before elective or semi-elective intubation, 
in stark contrast to practice in the UK 
or Australasia, where recent surveys[9,10,12] 
indicate that >90% of units are providing 
premedication. No consensus exists 
regarding the choice of agent/s, their dose/s 
or the ideal route of administration,[6] 
mirroring the findings of the present study 
and other surveys.[7-12]
Suxamethonium, as in other national 
surveys,[7-12] was the most commonly used 
muscle relaxant and is currently considered 
to be the best choice[17] because of its rapid 
onset, short duration of action and good 
side-effect profile.
In contrast to findings in the other national 
surveys,[7-12] midazolam was the preferred 
sedative in this SA study. Many participants 
used midazolam as the only premedication 
drug. Midazolam, a short-acting benzo-
diazepine with sedative properties, is 
inappropriate[17] because it has no analgesic 
properties. There are additional pitfalls to 
the use of midazolam as a single agent for 
intubation: Harte et al.,[18] examining the 
haemodynamic effect and pharmokinetic 
properties of midazolam, demonstrated 
no mitigation of the physiological changes 
attributed to intubation and found that 
the drug was associated with serious 
adverse effects during intubation. The use 
of midazolam has also been associated 
with hypotension and adverse neurological 
outcomes.[19,20] A Cochrane review found no 
evidence to support the use of midazolam as 
a sedative for infants, particularly preterm 
ones.[21] Infants receiving midazolam had 
longer hospital stays, and there were more 
adverse effects in the midazolam group 
when compared with placebo.[21]
A survey of premedication practices in 
the UK by Singh et al.[22] found the combin-
ation of fentanyl, atropine and suxameth-
onium to be the most common, followed by 
morphine, atropine and suxamethonium. A 
recent randomised controlled trial (RCT) in 
which either morphine alone or placebo was 
given 5 minutes before intubation demon-
strated inability of morphine to reduce either 
the adverse physiological changes attributed 
to intubation or the time required to complete 
the intubation process.[23] Moreover, safety 
concerns regarding the use of morphine 
for premedication in preterm infants have 
been raised, as it has been associated with 
prolonged amplified electroence phalo-
graphy (aEEG) depression, inde pendent 
of blood pressure changes.[24] Fen tanyl is 
preferred to morphine, as its more rapid 
onset of action may improve pain control 
during intubation.[25] Hamon et al.[26] have 
shown that short-term fentanyl infusion 
in preterm infants is not associated with 
changes in systemic and cerebral perfusion 
pressures.
Propofol was listed by one respondent as 
their premedication drug of choice. Propofol 
is a hypnotic agent without anaesthetic 
properties. Spontaneous breathing effort is 
maintained during the intubation process. 
Ghanta et al.[5] compared propofol with 
a combination of morphine, atropine and 
suxamethonium, which took 5 times longer 
to prepare. They reported faster intubation 
times, better oxygen saturation maintenance 
and shorter recovery times in the propofol 
group, and there was no difference in 
bradycardia or hypotension between the 
two groups.[5] A paucity of data remains 
regarding the use of propofol in infants; 
the Cochrane review by Shah et al.[27] only 
included the 63 infants in Ghanta et al.’s RCT. 
There are also significant concerns regarding 
the safety of propofol, Welzing et al.[28] 
demonstrating a significant drop in arterial 
blood pressure when propofol was injected 
as a fast push. Current pharmacokinetic 
Table 3. Premedication practices
Premedication practice Yes, n (%) No, n (%)
Written policy 47 (38.5) 75 (61.5)
Use of premedication 87 (71.9) 34 (28.1)
Routine use of sedatives 55 (63.2) 32 (36.8)
Routine use of muscle relaxants 21 (24.4) 65 (75.6)
Table 4. Combinations of premedication used
Agents
Respondents (N=87) 
n (%)
Midazolam + suxamethonium + atropine 1 (1.15)
Midazolam + atropine (when bradycardic) 5 (5.7)
Midazolam alone 16 (18.4)
Morphine + suxamethonium + atropine 7 (8.0)
Morphine + atropine 2 (2.3)
Morphine alone 7 (8.0)
Morphine + atropine (when bradycardic) 2 (2.3)
Ketamine + suxamethonium + atropine 6 (6.9)
Ketamine + cisatricurium + atropine 1 (1.15)
Ketamine + atropine 4 (4.6)
Fentanyl + suxamethonium + atropine 1 (1.15)
Propofol alone 1 (1.15)
Suxamethonium alone 1 (1.15)
Suxamethonium + atropine 4 (4.6)
Atropine alone 7 (8.0)
Atropine when bradycardic 3 (3.4)
Answered ‘yes’ for premed, no agents ticked 19 (21.8)
Table 5. Doses for premedication drugs
Drug Dose
Fentanyl 10 µg/kg
Ketamine 1 - 2 mg/kg
Midazolam 0.05 - 0.4 mg/kg
Morphine 0.05 - 0.2 mg/kg
Propofol 1 - 2 mg/kg
Suxamethonium 1 - 2 mg/kg
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studies on the use of propofol in infants 
indicate marked inter-individual variability 
and reduced clearance of propofol.[29] The 
Exploratory Propofol Dose Finding Study 
in Neonates (NEOPROP) is currently under 
way and aims to evaluate pharmacokinetics 
and pharmacodynamics of propofol and to 
determine the optimal dose in infants.[30] 
Following identification of a safe dose, RCTs 
are needed to assess safety and efficacy 
of propofol, both as a single agent and in 
combination with an analgesic agent.
The UK and Australasian surveys enjoyed 
high response rates from clinicians surveyed. 
The low rate of response to the current 
survey may not reflect true premedication 
practices, as SA doctors respond poorly 
to mail surveys despite high internet 
penetration, which influenced our decision 
to conduct a web-based survey.[31]
This is the first study to survey 
premedication practice prior to elective 
neonatal intubation in SA. The findings 
highlight a wide variation in practices and 
the need for written policies, particularly in 
the private sector. Further research is needed 
to determine the outcomes associated with 
premedication, the most appropriate agent/s 
and their optimal dose/s. A national network 
of neonatal units needs to be established 
to ensure representative data collection. 
The findings of this study could be used 
to inform local collaborative trials aimed 
at studying premedication for intubation 
in the neonatal period. Importantly, this 
survey may stimulate debate and discussion, 
culminating in a national premedication 
practice guideline.
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